Peptic Ulcer Market Report 2026

Peptic Ulcer Market Overview

• Peptic Ulcer market size has reached to $4.22 billion in 2025 • Expected to grow to $5.16 billion in 2030 at a compound annual growth rate (CAGR) of 4.3% • Growth Driver: Obesity Fuels The Expansion Of The Peptic Ulcer Market • Market Trend: Advancements In Peptic Ulcer Treatment With Combikit And Central Drugs Standard Control Organisation (CDSCO) Approval • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peptic Ulcer Market?

A peptic ulcer is an open sore or raw area in the stomach lining or intestine. It is primarily caused by the erosion of the stomach's protective lining or the upper part of the small intestine (duodenum). The common peptic ulcer symptoms include upper abdominal pain or discomfort and acid reflux symptoms like heartburn, sometimes accompanied by nausea. The main disease indications types are gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the lining of the stomach. Treatment of gastritis typically involves medications such as proton pump inhibitors and lifestyle modifications. The drugs used are proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other drugs, which are sold through distribution channels, such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

What Is The Peptic Ulcer Market Growth Forecast?

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $5.16 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing adoption of proton pump inhibitors and antibiotics, growth in hospital and private clinic treatment facilities, rising awareness about preventive care, innovation in non-invasive diagnostic techniques, expansion of e-commerce and retail pharmacy distribution channels. Major trends in the forecast period include rising adoption of ai-based diagnostic tools, personalized ulcer treatments using genomics, use of cloud and big data for patient monitoring, integration of iot devices for remote symptom tracking, advanced manufacturing of ulcer therapeutics.

Global Peptic Ulcer Market Segmentation

1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD) 2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs 3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce Subsegments: 1) By Gastritis: Acute Gastritis, Chronic Gastritis 2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer 3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer 4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD

What Are The Drivers Of The Peptic Ulcer Market?

The growing prevalence of obesity is expected to propel the growth of the peptic ulcer market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, typically resulting in an individual having a body mass index (BMI) of 30 or higher. Obesity can result from genetic, environmental, and lifestyle factors, such as a poor diet and a lack of physical activity. Obesity leads to the overproduction of stomach acid, weakens the stomach's protective mucosal lining, and contributes to developing peptic ulcers. Moreover, excess weight seems to promote inflammation in the gut, which can lead to the development of peptic ulcers. For instance, in May 2025, according to the World Health Organization, a Switzerland-based intergovernmental international organization, reported that in 2024, 35 million children under the age of 5 were overweight. Therefore, the growing prevalence of obesity is driving the growth of the peptic ulcer industry. The increasing smoking rates are expected to propel the growth of the peptic ulcer market in the coming future. Smoking refers to the act of breathing in and out the vapors of burning plant-based products such as tobacco or marijuana. Smoking is a well-known contributory factor to peptic ulcer disease. Smoking increases the incidence of peptic ulcers by harming the stomach and duodenal linings, decreasing blood supply to the stomach, and elevating stomach acid production. For instance, in November 2025, according to Organisation for Economic Co operation and Development, a France-based intergovernmental international organization, reported that across OECD countries, 14.8% of people aged 15 and over smoked daily in 2023. The proportion of daily smokers was highest in Türkiye, Hungary, and Greece, as well as in accession/partner countries Indonesia, Bulgaria, and China, where at least one in four people smoked daily. Therefore, the increasing smoking rates are driving the peptic ulcer industry.

Key Players In The Global Peptic Ulcer Market

Major companies operating in the peptic ulcer market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Global Peptic Ulcer Market Trends and Insights

Major companies operating in the peptic ulcer market are focusing on developing innovative solutions, such as combination therapy drug kits, to meet the rising demand for effective H. pylori eradication and ulcer management. Combination therapy kits integrate multiple active ingredients in a single regimen, improving treatment adherence and offering a more targeted approach than traditional single-drug therapies. For instance, in April 2023, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical formulations and APIs company, launched Combikit, an advanced three-drug formulation. The Combikit contains amoxicillin, clarithromycin, and esomeprazole, designed to simultaneously address bacterial elimination, acid suppression, and ulcer healing. It has received approval from the Central Drugs Standard Control Organisation (CDSCO) for treating duodenal ulcers associated with Helicobacter pylori (H. pylori) and for eradicating H. pylori in patients with active or healed peptic ulcers. By combining complementary mechanisms of action, the kit enhances treatment efficacy, reduces ulcer recurrence, and improves patient compliance, especially in regions with high H. pylori prevalence.

Regional Outlook

North America was the largest region in the peptic ulcer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peptic Ulcer Market?

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Peptic Ulcer Market Report 2026?

The peptic ulcer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.